Page Industries Reports Robust Revenue Growth in Latest Quarter Sales Volume Increases
US GDP Growth of 2 in Early 2026 Signals Continued Economic Resilience
Dating App Authenticity Push Sparks Investor Interest as Startups Tackle Fake Profiles
Robert Kiyosaki Predicts Gold at 10000 and Silver 200 Warns of Imminent Stock Market Crash
World Cup Campaigns Shaping Consumer Choices in Food Fashion and Travel
Italy Stocks End Lower as Investingcom Italy 40 Declines 076
Cohen Steers CNS Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds
UFI Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction
SnapOn Q1 2026 Earnings EPS Falls Short of Expectations Shares Edge Higher
KEX Q1 2026 Earnings EPS Beats Estimates by 66 Stock Edges Higher
CIA Q1 2026 Earnings EPS Miss Triggers Cautious Market Response
PERF Q1 2026 Earnings EPS Beats Estimates as Company Delivers Strong Profitability
Miluna Acquisition Corp Warrant MMTXW Holds Steady Near Support After Flat Session
Rush Street Interactive RSI Holds Above Support After Modest Decline
Xtant Medical Holdings XTNT Edges Higher Testing Key Resistance at 050
Gabelli Utility Trust GUT Faces Modest Decline Consolidates Between Key Support and Resistance
Franklin Financial Services FRAF Gains Ground Testing Key Levels After 225 Rally
Kathleen Kennedy Townsend Secures Buyer for 16 Million Cape Cod Property Amid Strong Coastal Real Estate Demand
ADAMH Q1 2026 Earnings Earnings Surge Past Estimates with 75 Surprise
Trinity Capital 7875 Notes TRINI Hold Near Par as Income Demand Steadies
CDP Q1 2026 Earnings EPS Slightly Beats Estimates on Stable Portfolio Performance
RYN Q1 2026 Earnings Stellar EPS Surprise Defies Low Expectations
Amcor Q1 2026 Earnings Adjusted EPS Falls Short of Expectations
GOTU Q4 2025 Earnings EPS Beat Estimates by 419 Amid Challenging Environment
Biogen Q1 2026 Earnings EPS Surges Past Estimates Stock Rises
HIVE Digital Technologies Q1 2026 Earnings Significant EPS Miss as Crypto Mining Headwinds Persist
SABS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline